These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 22537601)
1. Is on-demand treatment effective in patients with severe haemophilia? Aznar JA; Marco A; Jiménez-Yuste V; Fernández-Fontecha E; Pérez R; Soto I; Parra R; Moreno M; Mingot ME; Moret A; Haemophilia; 2012 Sep; 18(5):738-42. PubMed ID: 22537601 [TBL] [Abstract][Full Text] [Related]
2. [Prevention of joint damage in hemophilic children with early prophylaxis]. Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528 [TBL] [Abstract][Full Text] [Related]
3. The orthopaedic status of severe haemophiliacs in Spain. Aznar JA; Magallón M; Querol F; Gorina E; Tusell JM Haemophilia; 2000 May; 6(3):170-6. PubMed ID: 10792475 [TBL] [Abstract][Full Text] [Related]
4. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study. Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137 [TBL] [Abstract][Full Text] [Related]
6. Progression of haemophilic arthropathy in children: a Lithuanian--Danish comparative study. Saulyte Trakymiene S; Clausen N; Poulsen LH; Ingerslev J; Rageliene L Haemophilia; 2013 Mar; 19(2):212-8. PubMed ID: 23167920 [TBL] [Abstract][Full Text] [Related]
7. Cross sectional study to investigate the influence of treatment regimes on the development of haemophilic arthropathy. Hilberg T; Czepa D Hamostaseologie; 2009 Oct; 29 Suppl 1():S77-9. PubMed ID: 19763361 [TBL] [Abstract][Full Text] [Related]
8. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed. van Dijk K; Fischer K; van der Bom JG; Grobbee DE; van den Berg HM Haemophilia; 2005 Sep; 11(5):438-43. PubMed ID: 16128885 [TBL] [Abstract][Full Text] [Related]
9. When should prophylactic treatment in patients with haemophilia A and B start?--The German experience. Kreuz W; Escuriola-Ettingshausen C; Funk M; Schmidt H; Kornhuber B Haemophilia; 1998 Jul; 4(4):413-7. PubMed ID: 9873763 [TBL] [Abstract][Full Text] [Related]
10. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China. Wu R; Luke KH; Poon MC; Wu X; Zhang N; Zhao L; Su Y; Zhang J Haemophilia; 2011 Jan; 17(1):70-4. PubMed ID: 20579111 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors. Fischer K; Valentino L; Ljung R; Blanchette V Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542 [TBL] [Abstract][Full Text] [Related]
12. Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis. Olivieri M; Kurnik K; Pfluger T; Bidlingmaier C Haemophilia; 2012 May; 18(3):369-74. PubMed ID: 22032268 [TBL] [Abstract][Full Text] [Related]
13. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey. Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ; Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844 [TBL] [Abstract][Full Text] [Related]
14. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre. De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500 [TBL] [Abstract][Full Text] [Related]
15. Intraarticular bleeding in children with hemophilia: the prevention of arthropathy. Gregosiewicz A; Wośko I; Kandzierski G J Pediatr Orthop; 1989; 9(2):182-5. PubMed ID: 2494223 [TBL] [Abstract][Full Text] [Related]
16. Haemophilia care in Europe: the ESCHQoL study. Schramm W; Gringeri A; Ljung R; Berger K; Crispin A; Bullinger M; Giangrande PL; Von Mackensen S; Mantovani LG; Nemes L; Serban M; Haemophilia; 2012 Sep; 18(5):729-37. PubMed ID: 22639833 [TBL] [Abstract][Full Text] [Related]
18. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series. Valentino LA Haemophilia; 2009 May; 15(3):733-42. PubMed ID: 19298380 [TBL] [Abstract][Full Text] [Related]
19. [The orthopaedic status of a selected severe haemophilia group]. Windyga J; Stefańska E; Lopaciuk S; Juszyński A; Woźniak D; Strzelecki O Pol Arch Med Wewn; 2005 Jun; 113(6):562-9. PubMed ID: 16454446 [TBL] [Abstract][Full Text] [Related]
20. The overall effectiveness of prophylaxis in severe haemophilia. Panicker J; Warrier I; Thomas R; Lusher JM Haemophilia; 2003 May; 9(3):272-8. PubMed ID: 12694517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]